"The current assault on Medicaid demands the attention of every physician, every nurse, and every patient, which is to say, every American," says Alex McDonald, MD, CAQSM ...

As a first-line intervention for the treatment of insomnia, CBT-I may help clinicians address a modifiable treatment target ...

Dr. MedLaw explains the strategic role of prenuptial agreements in long-term asset protection for medical professionals.

Yun‑Yun Kathy Chen, MD, discusses her team's clinical trial evaluating nociceptive pain processing after a single‑injection axillary brachial plexus block.

As wildfire smoke becomes an increasingly common consequence of climate change, clinicians are facing new challenges in ...

Alexander B. Olawaiye, MD, shares how relacorilant’s recent approval might change the treatment landscape for ovarian cancer.

Update focuses on the evaluation, management, and monitoring of those at risk for, or living with, dyslipidemia.

Yen-Yi Juo, MD, MPH, and Michael Doney, MD, discuss the potential use of whole-body MRI–derived body composition z-scores.

Hao Yu, PhD, discusses his team’s findings showing the 2025 immigration ban could worsen clinician shortages in underserved ...

Robert J. Fontana, MD, and Kenneth D. Rothstein, MD, share how they deliver self-management education to patients with MASLD.

"Pharmacology is not merely chemistry; it is chemistry operating within living human systems," explains Christina A. Sheil, MD.

Luana Colloca, MD, PhD, and Chris Reist, MD, comment on how clinicians can use placebo and nocebo effects to improve care.